Kishi, Kentaro <br/><br/>
Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Oct 2003 
 - 4368-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Base Pair Mismatch<br/>Carcinoma, Squamous Cell--drug therapy<br/>Carrier Proteins<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Down-Regulation<br/>Doxorubicin--administration & dosage<br/>Esophageal Neoplasms--drug therapy<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Immunoenzyme Techniques<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>MutL Protein Homolog 1<br/>Neoadjuvant Therapy<br/>Neoplasm Proteins--metabolism<br/>Nuclear Proteins<br/>Postoperative Period<br/>Preoperative Care<br/>Prognosis<br/>Survival Rate<br/>Tumor Suppressor Protein p53--metabolism